[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355951-105":59,"doc-detail-355951-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","cardiovascular-disease-incidence-and-cancer-risk-in-two-large-european-prospective-cohorts","Cardiovascular disease incidence and cancer risk in two large European prospective cohorts","","Study assesses how incident cardiovascular disease (CVD) influences subsequent cancer risk using two large European prospective cohorts: EPIC and UK Biobank. The analysis includes 568,926 adults free of CVD, cancer, and type 2 diabetes at baseline and applies multivariable Cox proportional hazards models with CVD as a time-varying exposure. Meta-analysis pools cohort-specific hazard ratios over a median 10.9-year follow-up of 51,559 cancer cases, stratifying by time since CVD diagnosis and sex.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cardiovascular-disease-incidence-and-cancer-risk-in-two-large-european-prospective-cohorts/355951/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cardiovascular-disease-incidence-and-cancer-risk-in-two-large-european-prospective-cohorts/355951.png","ImageObject",300,407,{"name":92,"@type":93},"Ben ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-06","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",14,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What relationship does the study examine between cardiovascular disease and cancer risk?","Question",{"text":113,"@type":114},"The study investigates the association between incident cardiovascular disease and subsequent cancer risk, estimating cancer hazard ratios in relation to CVD events.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"How were participants selected for the analysis?",{"text":118,"@type":114},"The study included 568,926 adults from EPIC and UK Biobank who were free of CVD, cancer, and type 2 diabetes at baseline.",{"name":120,"@type":111,"acceptedAnswer":121},"What modeling strategy was used to estimate cancer risk after CVD?",{"text":122,"@type":114},"Multivariable Cox proportional hazards regression models were used, treating CVD as a time-varying exposure and accounting for time since CVD diagnosis and other lifestyle factors.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},355951,1790470166,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":105,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},2336478951081,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","DOI: 10.1002/ijc.70458  \nRES EARCH A RTICLE  \nCa ncer Epidemiology  \nCardiovascular disease incidence and cancer risk in two large European prospective cohorts  \nEmma Fontvieille 1  | Vivian Viallon 1 | Laia Peruchet-Noray 1,2 | Quan Gan 1 |  \nN. Charlotte Onland-Moret 3 | Yvonne Koop 3 | Anne Tjønneland 4,5 | Nicola Patricia Bondonno 4,6 | Verena Katzke 7 | Rudolf Kaaks 7 | Matthias B. Schulze 8,9 | Catarina Schiborn 8,10 | Calogero Saieva 11 |  \nVittorio Simeon 12 | Claudia Agnoli 13 | Rosario Tumino 14 | Fulvio Ricceri 15  | Leila Luján-Barroso 16 | Maria-José Sánchez 17,18,19 | Conchi Moreno-Iribas 19,20,21 | Konstantinos K. Tsilidis 22  | Marc J. Gunter 22 | Adam Butterworth 23,24 |  \nElio Riboli 22 | Heinz Freisling 1 | Pietro Ferrari 1  \n1Nutrition and Metabolism Branch, International Agency for Research on Cancer (IARC-WHO), Lyon, France 2Department of Clinical Sciences, Faculty of Medicine, University of Barcelona, Barcelona, Spain  \n3Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands 4Danish Cancer Society Research Center, Copenhagen, Denmark  \n5Department of Public Health, University of Copenhagen, Copenhagen, Denmark  \n6Nutrition and Health Innovation Research Institute, School of Medical and Health Sciences, Edith Cowan University, Perth, Australia 7Division of Cancer Epidemiology, German Cancer Research Centre (DKFZ), Heidelberg, Germany  \n8Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany 9Institute of Nutritional Science, University of Potsdam, Nuthetal, Germany  \n10German Center for Diabetes Research (DZD), München-Neuherberg, Germany  \n11Cancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network (ISPRO), Florence, Italy 12Unit of Medical Statistics, Department of Mental and Physical Health and Preventive Medicine, University ‘L.Vanvitelli’, Naples, Italy 13Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy  \n14Hyplean Association for Epidemiological Research, AIRE ONLUS, Ragusa, Italy  \n15Centre for Biostatistics, Epidemiology, and Public Health (C-BEPH), Department of Clinical and Biological Sciences, University of Turin, Turin, Italy 16Cancer Epidemiology Research ProgramjUnit of Nutrition and Cancer, Catalan Institute of Oncology (ICO-IDIBELL), L'Hospitalet de Llobregat, Spain 17Escuela Andaluza de Salud Pública (EASP), Granada, Spain  \n18Instituto de Investigación Biosanitaria ibs.GRANADA, Granada, Spain  \n19Centro de Investigación Biomédica en Red de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain 20Instituto de Salud Pública y Laboral de Navarra, Pamplona, Spain  \n21Navarra Institute for Health Research (IdiSNA), Pamplona, Spain  \n22Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK  \nAbbreviations: AF, atrial fibrillation; CHD, coronary heart disease; CI, confidence interval; CVD, cardiovascular diseases; EPIC, European Prospective Investigation into Cancer and nutrition; HF, heart failure; HR, hazard ratio; IARC, International Agency for Research on Cancer; T2D, type 2 diabetes; UKB, United Kingdom Biobank.  \nWhere authors are identified as personnel of the International Agency for Research on Cancer/World Health Organization, the authors alone are responsible for the views expressed in this article and they do not necessarily represent the decisions, policy or views of the International Agency for Research on Cancer/World Health Organization.  \nThis is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.  \n© 2026 The Author(s) . International Journal of Cancer published by John Wi","cbCaigfXPI7sZ0t1","https://ap.wps.com/l/cbCaigfXPI7sZ0t1","pdf",1813342,"English","# Abstract\n## Study design and participants\n## Statistical approach\n## Main findings","[{\"question\":\"What relationship does the study examine between cardiovascular disease and cancer risk?\",\"answer\":\"The study investigates the association between incident cardiovascular disease and subsequent cancer risk, estimating cancer hazard ratios in relation to CVD events.\"},{\"question\":\"How were participants selected for the analysis?\",\"answer\":\"The study included 568,926 adults from EPIC and UK Biobank who were free of CVD, cancer, and type 2 diabetes at baseline.\"},{\"question\":\"What modeling strategy was used to estimate cancer risk after CVD?\",\"answer\":\"Multivariable Cox proportional hazards regression models were used, treating CVD as a time-varying exposure and accounting for time since CVD diagnosis and other lifestyle factors.\"}]","Cardiovascular disease incidence and cancer risk in two large European prospective cohorts | PDF",1790121933,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fba35c4961d63e881025ab7ddb069431.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/4fcd7bbd585c6edf6f0dfa8ce029784a.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/caceefc6a5076d387ec1043c3b1e8fc8.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a2252cde9905e4a102fc65ce5f6b37a8.webp",980,1287]